UnitedHealth Group Incorporated (UNH) Shares Sold by Covington Investment Advisors Inc.

Covington Investment Advisors Inc. reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 21,795 shares of the healthcare conglomerate’s stock after selling 196 shares during the quarter. UnitedHealth Group accounts for about 1.5% of Covington Investment Advisors Inc.’s investment portfolio, making the stock its 25th largest holding. Covington Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $4,041,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. RB Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.4% during the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after buying an additional 7 shares during the last quarter. Altfest L J & Co. Inc. boosted its stake in shares of UnitedHealth Group by 0.3% during the 2nd quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock valued at $549,000 after buying an additional 10 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of UnitedHealth Group by 1.4% during the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares during the last quarter. Budros Ruhlin & Roe Inc. boosted its stake in shares of UnitedHealth Group by 0.8% during the 1st quarter. Budros Ruhlin & Roe Inc. now owns 1,832 shares of the healthcare conglomerate’s stock valued at $301,000 after buying an additional 15 shares during the last quarter. Finally, Hanson McClain Inc. boosted its stake in shares of UnitedHealth Group by 1.7% during the 1st quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after buying an additional 15 shares during the last quarter. Institutional investors own 86.14% of the company’s stock.

UnitedHealth Group Incorporated (NYSE:UNH) opened at $212.87 on Friday. The firm has a market cap of $204,104.14, a P/E ratio of 21.99, a price-to-earnings-growth ratio of 1.57 and a beta of 0.64. The company has a quick ratio of 0.72, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company earned $2.17 earnings per share. research analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This news story was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.com-unik.info/2017/11/04/unitedhealth-group-incorporated-unh-shares-sold-by-covington-investment-advisors-inc.html.

Several research firms have recently commented on UNH. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Credit Suisse Group began coverage on UnitedHealth Group in a research note on Thursday. They set an “outperform” rating and a $233.00 target price for the company. Mizuho reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Tuesday, October 24th. Oppenheimer Holdings, Inc. increased their target price on UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $219.00 target price (up from $210.00) on shares of UnitedHealth Group in a research note on Thursday, October 19th. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and an average target price of $216.65.

In other news, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now directly owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the transaction, the director now directly owns 1,818,898 shares in the company, valued at $348,700,935.58. The disclosure for this sale can be found here. Insiders have sold 72,149 shares of company stock worth $14,212,342 over the last three months. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit